CD8A and neoplasm: We found that CD8+ tumor infiltrating lymphocytes (TILs) isolated from tumor-bearing mice treated with Vax/aGITR/aPD-1 had a significantly higher frequency of CD8+ T cells specific for OVA257-264 and expressing CD107a compared to controls, suggesting these T cells have greater potential to target tumor cells (Figure 3B).